MX2009006699A - Composicion y metodo para preparar tabletas oralmente disgregantes que contienen una alta dosis de ingredientes farmaceuticamente activos. - Google Patents
Composicion y metodo para preparar tabletas oralmente disgregantes que contienen una alta dosis de ingredientes farmaceuticamente activos.Info
- Publication number
- MX2009006699A MX2009006699A MX2009006699A MX2009006699A MX2009006699A MX 2009006699 A MX2009006699 A MX 2009006699A MX 2009006699 A MX2009006699 A MX 2009006699A MX 2009006699 A MX2009006699 A MX 2009006699A MX 2009006699 A MX2009006699 A MX 2009006699A
- Authority
- MX
- Mexico
- Prior art keywords
- orally disintegrating
- disintegrating tablets
- composition
- api
- active ingredients
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Abstract
La presente invención se refiere a composiciones y a métodos mejorados para preparar tabletas oralmente disgretantes (COD). En un aspecto de la presente invención, la COD contiene además al menos un ingrediente activo farmacéutico (API). En otro aspecto de la presente invención, la COD contiene una concentración elevada de al menos un API. Específicamente, las COD descritas en esta invención que contienen una concentración elevada de API pueden contener hasta aproximadamente el 70% p/p de ingrediente activo farmacéutico en una dosis unitaria, mientras que al mismo tiempo exhiben los convenientes atributos de tiempo de disgregación rápido, dureza y friabilidad aceptables para atravesar envases tipo blíster o para ser embotellados y una sensación bucal aceptable.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87638306P | 2006-12-21 | 2006-12-21 | |
US94820807P | 2007-07-06 | 2007-07-06 | |
US95263807P | 2007-07-30 | 2007-07-30 | |
PCT/US2007/026185 WO2008079343A2 (en) | 2006-12-21 | 2007-12-20 | Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009006699A true MX2009006699A (es) | 2009-06-30 |
Family
ID=39345530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009006699A MX2009006699A (es) | 2006-12-21 | 2007-12-20 | Composicion y metodo para preparar tabletas oralmente disgregantes que contienen una alta dosis de ingredientes farmaceuticamente activos. |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100055179A1 (es) |
EP (1) | EP2101739A2 (es) |
AU (1) | AU2007338751A1 (es) |
CA (1) | CA2673458A1 (es) |
MX (1) | MX2009006699A (es) |
WO (1) | WO2008079343A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US20090208576A1 (en) | 2006-03-31 | 2009-08-20 | Gandhi Anilkumar S | Orally Disintegrating Tablets |
GB2495563B (en) * | 2009-04-28 | 2014-12-03 | Isp Investments Inc | Co-processed excipient compositions |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
WO2018142296A2 (en) * | 2017-02-01 | 2018-08-09 | Zion Azar | Systems methods devices apparatuses circuits and computer executable code for production and topical application of a therapeutic substance |
WO2019147650A1 (en) * | 2018-01-23 | 2019-08-01 | Gila Therapeutics, Inc. | Peptide yy pharmaceutical formulations, compositions, and methods |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2485914A1 (fr) * | 1980-07-01 | 1982-01-08 | Oreal | Appareil de mesure des caracteristiques elastiques d'une peau |
CH658188A5 (de) * | 1984-03-23 | 1986-10-31 | Ciba Geigy Ag | Lagerstabile schnellzerfallende pharmazeutische presslinge. |
AU2636797A (en) * | 1996-04-16 | 1997-11-07 | Novartis Consumer Health S.A. | Fast disintegrating oral dosage form |
NZ507271A (en) * | 1998-03-06 | 2003-03-28 | Eurand Internat S | Fast disintegrating tablets |
US7815937B2 (en) * | 1998-10-27 | 2010-10-19 | Biovail Laboratories International Srl | Quick dissolve compositions and tablets based thereon |
WO2001012161A1 (en) * | 1999-08-17 | 2001-02-22 | Novartis Consumer Health S.A. | Rapidly dissolving dosage form and process for making same |
EP1244428A1 (en) * | 1999-12-06 | 2002-10-02 | Edward Mendell Co., Inc. | Pharmaceutical superdisintegrant |
US20030185886A1 (en) * | 2000-05-26 | 2003-10-02 | Hanmi Pharm. Co., Ltd. | Process for the preparation of rapidly disintegrating tablet |
US7927623B2 (en) * | 2001-02-15 | 2011-04-19 | Mitsubishi Tanabe Pharma Corporation | Tablets quickly disintegrated in oral cavity |
US6998139B2 (en) * | 2001-03-15 | 2006-02-14 | Astellas Pharma Inc. | Bitterness-reduced intrabuccally quick disintegrating tablets and method for reducing bitterness |
US7037524B2 (en) * | 2001-10-03 | 2006-05-02 | Herbalscience, Llc | Oral delivery of a botanical |
MXPA04004181A (es) * | 2001-11-02 | 2005-01-25 | Sandoz Ag | Procedimiento para preparar composiciones de ribavirina de alta carga, de rapida disolucion. |
SE0200154D0 (sv) * | 2002-01-21 | 2002-01-21 | Galenica Ab | New process |
US20030161875A1 (en) * | 2002-02-27 | 2003-08-28 | Deepak Murpani | Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors |
AU2003221326A1 (en) * | 2002-03-06 | 2003-09-16 | Kyowa Hakko Kogyo Co., Ltd. | Tablets quickly disintegrating in oral cavity |
WO2003096874A2 (en) * | 2002-05-15 | 2003-11-27 | Sun Pharmaceutical Industries Limited | Coated sustained release tablets of a hygroscopic compound for once-a-day therapy |
US20050215498A1 (en) * | 2002-05-31 | 2005-09-29 | Guenther Eissner | Method for the protection of endothelial and epithclial cells during chemotherapy |
JP2006509771A (ja) * | 2002-11-25 | 2006-03-23 | パーデュー・リサーチ・ファウンデイション | マンノースをベースとした速溶性錠剤 |
WO2004064815A1 (en) * | 2003-01-21 | 2004-08-05 | Smartrix Technologies Inc. | Oral dosage formulation |
JP3841804B2 (ja) * | 2003-10-15 | 2006-11-08 | 富士化学工業株式会社 | 口腔内速崩壊性錠剤用の組成物 |
US8545881B2 (en) * | 2004-04-19 | 2013-10-01 | Eurand Pharmaceuticals, Ltd. | Orally disintegrating tablets and methods of manufacture |
US20050244347A1 (en) * | 2004-04-30 | 2005-11-03 | Mehra Dev K | Oral care products comprising calcium phosphates |
ZA200701576B (en) * | 2004-04-30 | 2008-09-25 | Astellas Pharma Inc | Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition |
US9884014B2 (en) * | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
AU2006285673B2 (en) * | 2005-09-01 | 2010-12-02 | Eisai R&D Management Co., Ltd. | Method for preparation of pharmaceutical composition having improved disintegratability |
WO2007028247A1 (en) * | 2005-09-09 | 2007-03-15 | University Of Manitoba | Fast-disintegrating epinephrine tablets for buccal or sublingual administration |
WO2008005534A2 (en) * | 2006-07-06 | 2008-01-10 | Forest Laboratories, Inc. | Orally dissolving formulations of memantine |
EP1908748A1 (en) * | 2006-10-05 | 2008-04-09 | Krka | Process for the preparation of memantine and its hydrochloric acid salt form |
-
2007
- 2007-12-20 EP EP07867944A patent/EP2101739A2/en not_active Withdrawn
- 2007-12-20 CA CA002673458A patent/CA2673458A1/en not_active Abandoned
- 2007-12-20 US US12/519,927 patent/US20100055179A1/en not_active Abandoned
- 2007-12-20 AU AU2007338751A patent/AU2007338751A1/en not_active Abandoned
- 2007-12-20 WO PCT/US2007/026185 patent/WO2008079343A2/en active Application Filing
- 2007-12-20 MX MX2009006699A patent/MX2009006699A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2101739A2 (en) | 2009-09-23 |
CA2673458A1 (en) | 2008-07-03 |
WO2008079343A3 (en) | 2008-08-14 |
WO2008079343A2 (en) | 2008-07-03 |
AU2007338751A1 (en) | 2008-07-03 |
US20100055179A1 (en) | 2010-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200630123A (en) | Oral medicinal product with modified release of at least one active principle in multimicrocapsular form | |
TW200505498A (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
WO2004000197A3 (en) | Quick dissolve compositions and tablets based thereon | |
MY125766A (en) | Flash-melt oral dosage formulation | |
WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
TW200633730A (en) | Oral disintegrating dosage forms | |
IL179718A0 (en) | Pharmaceutical composition containing irbesartan | |
MX2009006699A (es) | Composicion y metodo para preparar tabletas oralmente disgregantes que contienen una alta dosis de ingredientes farmaceuticamente activos. | |
HK1056326A1 (en) | Process for preparing pharmaceutical compositions for use with soft gelatin formulations | |
MY127350A (en) | Flash-melt oral dose formulations | |
AP2003002763A0 (en) | Controlled release formulations for oral administration | |
UA101407C2 (ru) | Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат | |
HK1067299A1 (en) | Pharmaceutical compositions containing terbinafineand use thereof | |
WO2006053089A3 (en) | Methods and formulations for making pharmaceutical compositions containing bupropion | |
EA201001108A1 (ru) | Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения | |
MXPA06000332A (es) | Nueva composicion farmaceutica solida que comprende amisulprida. | |
ATE401075T1 (de) | Cytisinehaltiges arzneimittel | |
WO2005115346A3 (en) | Pharmaceutical composition containing risperidone | |
WO2007120838A3 (en) | Rapidly disintegrating solid oral dosage form of liquid dispersions | |
MXPA04004907A (es) | Composiciones de acetaminofen. | |
HUP0203148A2 (hu) | Mirtazapint tartalmazó orálisan dezintegrálódó készítmény | |
ZA200408929B (en) | Process for the preparation of pharmaceutical composition containing antiretroviral protease inhibitor with improve bioavalability | |
WO2008147245A3 (fr) | Composition pharmaceutique de proxodolol à libération contrôlée | |
GB0224492D0 (en) | Pharmaceutical compositions of rapid drug delivery system to carry active ingredients for fast dissolving tablets by mouth administration | |
TW200621314A (en) | Methods and formulations for making pharmaceutical compositions containing bupropion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |